These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8126760)

  • 1. Effect of endotoxin on tirilazad mesylate (U74006F) pharmacokinetic parameters in neonatal calves.
    Rose ML; Semrad SD; Putnam ML; Brown SA
    J Vet Pharmacol Ther; 1993 Dec; 16(4):438-45. PubMed ID: 8126760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tirilazad mesylate (U74006F) on eicosanoid and tumor necrosis factor generation in healthy and endotoxemic neonatal calves.
    Semrad SD; Rose ML; Adams JL
    Circ Shock; 1993 Aug; 40(4):235-42. PubMed ID: 8375024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of tirilazad mesylate for treatment of endotoxemia in neonatal calves.
    Rose ML; Semrad SD
    Am J Vet Res; 1992 Dec; 53(12):2305-10. PubMed ID: 1476313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of repeated administration of tirilazad mesylate on healthy and endotoxemic calves: a pilot study.
    Semrad SD; Dubielzig R
    Can J Vet Res; 1994 Jan; 58(1):67-70. PubMed ID: 8143257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/day administered over 5-10 days in healthy volunteers.
    Fleishaker JC; Hulst LK; Peters GR
    Int J Clin Pharmacol Ther; 1994 May; 32(5):223-30. PubMed ID: 7921515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tirilazad mesylate (U74006F) on cerebral oxygen consumption, and reactivity of cerebral blood flow to carbon dioxide in healthy volunteers.
    Olsen KS; Videbaek C; Agerlin N; Krøll M; Bøge-Rasmussen T; Paulson OB; Gjerris F
    Anesthesiology; 1993 Oct; 79(4):666-71. PubMed ID: 8214745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of tirilazad (U74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat.
    Laizure SC; Franklin LK; Kaiser DG; Williams CL; Stevens RC; Sanders PL; Miller M
    Drug Metab Dispos; 1993; 21(5):951-4. PubMed ID: 7902261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: I. Single-dose administration.
    Fleishaker JC; Peters GR; Cathcart KS
    J Clin Pharmacol; 1993 Feb; 33(2):175-81. PubMed ID: 8382708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of phenytoin on the pharmacokinetics of tirilazad mesylate in healthy male volunteers.
    Fleishaker JC; Hulst LK; Peters GR
    Clin Pharmacol Ther; 1994 Oct; 56(4):389-97. PubMed ID: 7955800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple-dose administration.
    Fleishaker JC; Peters GR; Cathcart KS; Steenwyk RC
    J Clin Pharmacol; 1993 Feb; 33(2):182-90. PubMed ID: 8440768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and effects of repeated administration of phenylbutazone in neonatal calves.
    Semrad SD; McClure JT; Sams RA; Kaminski LM
    Am J Vet Res; 1993 Nov; 54(11):1906-12. PubMed ID: 8291771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age and gender on tirilazad pharmacokinetics in humans.
    Hulst LK; Fleishaker JC; Peters GR; Harry JD; Wright DM; Ward P
    Clin Pharmacol Ther; 1994 Apr; 55(4):378-84. PubMed ID: 8162663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs.
    Matsui T; Asano T
    Neurosurgery; 1994 Jun; 34(6):1035-9; discussion 1039. PubMed ID: 8084388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of a pharmacokinetic/pharmacodynamic interaction between nimodipine and tirilazad mesylate in healthy volunteers.
    Fleishaker JC; Hulst LK; Peters GR
    J Clin Pharmacol; 1994 Aug; 34(8):837-41. PubMed ID: 7962672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats.
    Yue G; Sun FF; Dunn C; Yin K; Wong PY
    J Pharmacol Exp Ther; 1996 Jan; 276(1):265-70. PubMed ID: 8558441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacokinetics of tirilazad mesylate in healthy volunteers and stable subjects with mild liver cirrhosis.
    Pearson LK; Fleishaker JC; Peters GR
    Eur J Clin Pharmacol; 1996; 50(4):299-304. PubMed ID: 8803523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender does not affect the degree of induction of tirilazad clearance by phenobarbital.
    Fleishaker JC; Pearson LK; Peters GR
    Eur J Clin Pharmacol; 1996; 50(1-2):139-45. PubMed ID: 8739825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of tirilazad in human: 4. effect of finasteride on tirilazad clearance and reduced metabolite formation.
    Fleishaker JC; Pearson PG; Wienkers LC; Pearson LK; Moore TA; Peters GR
    J Pharmacol Exp Ther; 1998 Nov; 287(2):591-7. PubMed ID: 9808685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of the 21-aminosteroid lipid peroxidation inhibitor tirilazad mesylate (U74006F) on hepatic endothelium in experimental hemorrhagic shock.
    Eversole RR; Smith SL; Beuving LJ; Hall ED
    Circ Shock; 1993 Jun; 40(2):125-31. PubMed ID: 8508516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of C5a by polymorphonuclear leukocytes (PMNs) after focal cerebral ischemia. I. Effect of tirilazad mesylate intervention on C5a uptake by PMNs.
    Hetland G; del Zoppo GJ; Mori E; Thomas WS; Hugli TE
    Immunopharmacology; 1994; 27(3):191-8. PubMed ID: 8071059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.